View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/CMS | RIN: 0938-AQ41 | Publication ID: Fall 2015 |
Title: Covered Outpatient Drugs (CMS-2345-F)(Section 610 Review) | |
Abstract:
This final rule revises requirements pertaining to Medicaid reimbursement for covered outpatient drugs to implement provisions of the Affordable Care Act. This rule also revises other requirements related to covered outpatient drugs, including key aspects of Medicaid coverage, payment, and the drug rebate program. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Economically Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: Yes | Unfunded Mandates: No |
RFA Section 610 Review: Section 610 Review | |
CFR Citation: 42 CFR 447 | |
Legal Authority: Pub. L. 111- 48, sec 2501 Pub. L. 111- 48, 2503 Pub. L. 111- 48, 3301(d)(2) Pub. L. 111-152, sec 1206 Pub. L. 111-8, sec 221 |
Legal Deadline:
|
||||||||||||
Timetable:
|
Additional Information: Includes Retrospective Review under E.O. 13563. | |
Regulatory Flexibility Analysis Required: Yes | Government Levels Affected: State, Tribal |
Small Entities Affected: Businesses | Federalism: No |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: Yes | |
Related RINs: Related to 0938-AP26, Related to 0938-AP67 | |
Agency Contact: Wendy Tuttle Health Insurance Specialist Department of Health and Human Services Centers for Medicare & Medicaid Services S1-01-16, Center for Medicaid and CHIP Services, MS: S2-14-26, 7500 Security Boulevard, Baltimore, MD 21244 Phone:410 786-8690 Email: wendy.tuttle@cms.hhs.gov |